NanoViricides, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.2M | $-2.0M | $-2.2M | $-1.8M | $-2.1M | $-2.2M | $-2.0M | $-3.1M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $127.7K | $127.6K | $131.0K | $130.8K | $159.1K | $189.1K | $193.8K | $193.5K |
| Amortization | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-2.1M | $-1.9M | $-2.0M | $-1.6M | $-1.7M | $-2.0M | $-2.2M | $-2.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $1 | $0 | $-1 | $84.3K | $10.2K | $0 | $0 | $46.8K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-1 | $0 | $1 | $-84.3K | $-10.2K | $0 | $0 | $-46.8K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.7M | $-6.7K | $6.1M | $1.2M | $728.1K | $575.5K | $2.3M | $1.7M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-2.1M | $-1.9M | $-2.0M | $-1.7M | $-1.7M | $-2.0M | $-2.2M | $-2.6M |